Synergistic Antitumor Effect of Oligogalacturonides and Cisplatin on Human Lung Cancer A549 Cells

Cisplatin (DPP), a clinically potent antineoplastic agent, is limited by its severe adverse effects. The aim of this study was to investigate the effect of oligogalacturonides (OGA) and DDP on human lung cancer A549 cells. The combined use of OGA and DDP had a synergistic effect on the growth inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Cian-Song, Huang, Ai-Chun, Huang, Ping-Hsiu, Lo, Diana, Wang, Yuh-Tai, Wu, Ming-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032352/
https://www.ncbi.nlm.nih.gov/pubmed/29903991
http://dx.doi.org/10.3390/ijms19061769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032352/
https://www.ncbi.nlm.nih.gov/pubmed/29903991
http://dx.doi.org/10.3390/ijms19061769

Ejemplares similares